Teacher Retirement System of Texas Portfolio holdings
AUM
$23.8B
1-Year Return
25.15%
This Quarter Return
+8.63%
1 Year Return
+25.15%
3 Year Return
+104.39%
5 Year Return
+185.58%
10 Year Return
+422.47%
AUM
$21B
AUM Growth
+$3.45B
(+20%)
Cap. Flow
+$2.44B
Cap. Flow
% of AUM
11.62%
Top 10 Holdings %
Top 10 Hldgs %
24.42%
Holding
1,722
New
166
Increased
827
Reduced
483
Closed
238
Top Buys
| 1 |
iShares MSCI India ETF
INDA
|
$252M |
| 2 |
Flutter Entertainment
FLUT
|
$169M |
| 3 |
Apple
AAPL
|
$116M |
| 4 |
NVIDIA
NVDA
|
$113M |
| 5 |
Microsoft
MSFT
|
$109M |
Top Sells
| 1 |
Informatica
INFA
|
$353M |
| 2 |
SPDR Gold Trust
GLD
|
$48.4M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
$44.2M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
$44.2M |
| 5 |
PTC
PTC
|
$40.2M |
Sector Composition
| 1 | Technology | 25.17% |
| 2 | Financials | 12.62% |
| 3 | Healthcare | 11.82% |
| 4 | Consumer Discretionary | 10.92% |
| 5 | Industrials | 10.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1451
Zymeworks
ZYME
$1.14B
| $145K | ﹤0.01% |
11,527
+1,466
| +15% | +$18.4K |
|
1452
Arbutus Biopharma
ABUS
$805M
| $137K | ﹤0.01% |
+35,500
| New | +$137K |
|
1453
Pliant Therapeutics
PLRX
$114M
| $136K | ﹤0.01% |
+12,104
| New | +$136K |
|
1454
89bio
ETNB
$1.32B
| $133K | ﹤0.01% |
17,921
+2,226
| +14% | +$16.5K |
|
1455
ImmunityBio
IBRX
$2.27B
| $129K | ﹤0.01% |
34,675
+5,077
| +17% | +$18.9K |
|
1456
Warner Bros
WBD
$30B
| $129K | ﹤0.01% |
15,585
-29,464
| -65% | -$244K |
|
1457
Sana Biotechnology
SANA
$752M
| $127K | ﹤0.01% |
30,588
+1,539
| +5% | +$6.39K |
|
|
INN
1458
Summit Hotel Properties
INN
$614M
| $122K | ﹤0.01% |
17,845
-9,176
| -34% | -$62.7K |
|
1459
Taboola.com
TBLA
$1,000M
| $121K | ﹤0.01% |
35,929
+8,812
| +32% | +$29.7K |
|
1460
Erasca
ERAS
$457M
| $116K | ﹤0.01% |
+42,361
| New | +$116K |
|
1461
Liquidia Corp
LQDA
$2.48B
| $115K | ﹤0.01% |
11,497
+650
| +6% | +$6.5K |
|
1462
Humacyte
HUMA
$226M
| $114K | ﹤0.01% |
+20,907
| New | +$114K |
|
1463
Garrett Motion
GTX
$2.64B
| $112K | ﹤0.01% |
+13,691
| New | +$112K |
|
1464
Regenxbio
RGNX
$490M
| $110K | ﹤0.01% |
+10,502
| New | +$110K |
|
1465
Altimmune
ALT
$334M
| $109K | ﹤0.01% |
17,782
+2,270
| +15% | +$13.9K |
|
1466
Savara
SVRA
$643M
| $105K | ﹤0.01% |
24,743
+8,050
| +48% | +$34.2K |
|
1467
EyePoint Pharmaceuticals
EYPT
$966M
| $99K | ﹤0.01% |
12,410
+2,024
| +19% | +$16.1K |
|
1468
Allogene Therapeutics
ALLO
$255M
| $95K | ﹤0.01% |
34,038
+2,042
| +6% | +$5.7K |
|
1469
Payoneer
PAYO
$2.4B
| $92K | ﹤0.01% |
+12,186
| New | +$92K |
|
1470
Scholar Rock
SRRK
$3.02B
| $88K | ﹤0.01% |
+11,002
| New | +$88K |
|
1471
MindMed
MNMD
$702M
| $87K | ﹤0.01% |
15,290
+2,901
| +23% | +$16.5K |
|
1472
Nuvation Bio
NUVB
$1.33B
| $85K | ﹤0.01% |
37,271
+7,599
| +26% | +$17.3K |
|
|
SAGE
1473
DELISTED
Sage Therapeutics
SAGE
| $82K | ﹤0.01% |
+11,322
| New | +$82K |
|
1474
Tango Therapeutics
TNGX
$772M
| $82K | ﹤0.01% |
+10,713
| New | +$82K |
|
1475
Alector
ALEC
$305M
| $79K | ﹤0.01% |
16,918
+2,197
| +15% | +$10.3K |
|